A prospective randomized double-blind clinical study was performed to investigate corneal wound healing after treatment either with an eye gel containing calf blood extract or an eye ointment containing vitamin A and dexpanthenol. A total of 54 outpatients were included in this study, all treated for corneal foreign body injury. The size of the corneal lesions was measured by planimetry on days 0, 1, and on the following days until complete epithelial healing occurred. Results showed the calf blood extract eye gel to be statistically more effective in promoting corneal wound healing, especially in patients with wound areas larger than 6 mm2.

Keywords:
Corneal wound healing, Vitamin A and dexpanthenol ointment, Calf blood extract gel
1.
Erbe W, Herrmann R, Körner WF, Rohde-Germann H, Straub W: Our experience with Solcoseryl®-eye gel in the treatment of corneal lesions: A randomised double-blind study. Ophthalmologica 1984;188:1–4.
2.
Menna F: Therapeutic effects in ocular lesions, obtained by systemic and topical administration of an activator of the oxygen metabolism. Ophthalmologica 1980;180(suppl 1):1–50.
3.
Nemeth B, Bencsik R, Opauszki A: Therapeutische Erfahrungen mit einem Blutextrakt bei Kornealäsionen. Klin Monatsbl Augenheilkd 1981;178:390–391.
4.
Haydon: Die Wirkung von Solcoseryl®-Augen-Gel in Kombination mit Neomycin und Bacitracin auf die Heilung von Hornhautläsionen nach Fremdkörperentfernung. Klin Monatsbl Augenheilkd 1983;183:213–215.
5.
Nakamura M, Ofuji K, Chikama T, Nishida T: Combined effects of substance P and insulin-like growth factor-1 on corneal epithelial wound closure of rabbit in vivo. Curr Eye Res 1997;16:275–278.
6.
Callizo J, Cervello I, Mayayo E, Mallol J: Corneal wound healing in rabbit eye: Activity of a fibronectin-splitting product. Cornea 1996;15:263–270.
7.
Smolin G, Okumoto M: Vitamin A acid and corneal epithelial wound healing. Ann Ophthalmol 1981;13:563–566.
8.
Ubels JL, Edelhauser HF, Austin KH: Healing of experimental corneal wounds treated with topically applied retinoids. Am J Ophthalmol 1983;95:353–358.
9.
Göbbels M, Gross D: Klinische Studie zur Wirksamkeit eines dexpanthenolhaltigen Tränenersatzmittels (Siccaprotect®) bei der Behandlung trockener Augen. Klin Monatsbl Augenheilkd 1996;209:84–88.
10.
Kastl PR, Rosenthal WN, Batlle I, Karcioglu Z: Topical vitamin A ointment increases healing of cataract incisions. Ann Ophthalmol 1987;19:175–177.
11.
Haselmann G, Pufrich K, Haselmann H: Zur Behandlung von Epithelschäden der Cornea. Ophthalmologie 1952;6:29.
12.
Jakob HM: Dexpanthenol. DAZ 1995;23:2102.
13.
Spessotto P, Dri P, Baschong W, Mittenzwei H, Patriarca P: Effect of protein-free dialysate from calf blood on human monocyte differentiation in vitro. Arzneimittelforschung 1993;43:747–751.
14.
Studer O: A comparative clinical study of Solcoseryl®-eye gel and cysteine eye-gel 2.4% in the treatment of foreign body injuries of the cornea. Ophthalmic Res 1984;16:179–184.
15.
Kuniaka T, Senga Y, Senga H, Weiner M: Nature of enhanced mitochondrial oxidative metabolism by a calf blood extract. J Cell Physiol 1991;146:148–155.
16.
Krannig HM, Rohde-Germann H, Straub W: Therapy of corneal erosions and ‘dry eye’ with Solcoseryl® and Vitasic® eye drops. Ophthalmologica 1989;199:100–105.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.